Global and United States Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 06-Oct-2020
No. of pages: 99
Inquire Before Buying

Global Biosimilar Monoclonal Antibody Scope and Market Size

Biosimilar Monoclonal Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Synthetic Chemicals

- Biopharmaceuticals

- Others

Market segment by Application, split into

- Chronic & Autoimmune Diseases

- Oncology

- Others

Based on regional and country-level analysis, the Biosimilar Monoclonal Antibody market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilar Monoclonal Antibody market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Biocon

- Accord Healthcare

- AET Biotech

- Amgen

- Celltrion

- Reddy's Laboratories

- Hospira

- 3SBio

- Allergan

- Alvartis

Global and United States Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Synthetic Chemicals
1.2.3 Biopharmaceuticals
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibody Market Share by Application: 2020 VS 2026
1.3.2 Chronic & Autoimmune Diseases
1.3.3 Oncology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2015-2026)
2.2 Global Biosimilar Monoclonal Antibody Growth Trends by Regions
2.2.1 Biosimilar Monoclonal Antibody Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilar Monoclonal Antibody Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Monoclonal Antibody Players by Market Size
3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2015-2020)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2015-2020)
3.2 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilar Monoclonal Antibody Revenue
3.4 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2019
3.5 Key Players Biosimilar Monoclonal Antibody Area Served
3.6 Key Players Biosimilar Monoclonal Antibody Product Solution and Service
3.7 Date of Enter into Biosimilar Monoclonal Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Monoclonal Antibody Breakdown Data by Type (2015-2026)
4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2015-2020)
4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2021-2026)
5 Biosimilar Monoclonal Antibody Breakdown Data by Application (2015-2026)
5.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Application (2015-2020)
5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biosimilar Monoclonal Antibody Market Size (2015-2026)
6.2 North America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
6.3 North America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
6.4 North America Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibody Market Size (2015-2026)
7.2 Europe Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
7.4 Europe Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Biosimilar Monoclonal Antibody Market Size (2015-2026)
8.2 China Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
8.3 China Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
8.4 China Biosimilar Monoclonal Antibody Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Biosimilar Monoclonal Antibody Market Size (2015-2026)
9.2 Japan Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
9.3 Japan Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
9.4 Japan Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Biosimilar Monoclonal Antibody Market Size (2015-2026)
10.2 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2015-2020)
10.3 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2015-2020)
10.4 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Details
11.1.2 Biocon Business Overview
11.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
11.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2015-2020))
11.1.5 Biocon Recent Development
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Details
11.2.2 Accord Healthcare Business Overview
11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
11.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.2.5 Accord Healthcare Recent Development
11.3 AET Biotech
11.3.1 AET Biotech Company Details
11.3.2 AET Biotech Business Overview
11.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
11.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.3.5 AET Biotech Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
11.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.4.5 Amgen Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
11.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.5.5 Celltrion Recent Development
11.6 Reddy's Laboratories
11.6.1 Reddy's Laboratories Company Details
11.6.2 Reddy's Laboratories Business Overview
11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Introduction
11.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.6.5 Reddy's Laboratories Recent Development
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Hospira Business Overview
11.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
11.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.7.5 Hospira Recent Development
11.8 3SBio
11.8.1 3SBio Company Details
11.8.2 3SBio Business Overview
11.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
11.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.8.5 3SBio Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
11.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.9.5 Allergan Recent Development
11.10 Alvartis
11.10.1 Alvartis Company Details
11.10.2 Alvartis Business Overview
11.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
11.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2015-2020)
11.10.5 Alvartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Synthetic Chemicals
Table 4. Key Players of Biopharmaceuticals
Table 5. Key Players of Others
Table 6. Global Biosimilar Monoclonal Antibody Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Biosimilar Monoclonal Antibody Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Biosimilar Monoclonal Antibody Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Biosimilar Monoclonal Antibody Market Share by Regions (2015-2020)
Table 10. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Biosimilar Monoclonal Antibody Market Share by Regions (2021-2026)
Table 12. Biosimilar Monoclonal Antibody Market Market Trends
Table 13. Biosimilar Monoclonal Antibody Market Drivers
Table 14. Biosimilar Monoclonal Antibody Market Challenges
Table 15. Biosimilar Monoclonal Antibody Market Restraints
Table 16. Global Biosimilar Monoclonal Antibody Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Biosimilar Monoclonal Antibody Market Share by Players (2015-2020)
Table 18. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibody as of 2019)
Table 19. Global Biosimilar Monoclonal Antibody by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biosimilar Monoclonal Antibody Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Biosimilar Monoclonal Antibody Market Size Share by Type (2015-2020)
Table 25. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2021-2026)
Table 26. Global Biosimilar Monoclonal Antibody Market Size Share by Application (2015-2020)
Table 27. Global Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Biosimilar Monoclonal Antibody Market Size Share by Application (2021-2026)
Table 29. North America Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 31. North America Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 33. North America Biosimilar Monoclonal Antibody Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Biosimilar Monoclonal Antibody Market Share by Country (2015-2020)
Table 35. Europe Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 37. Europe Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 39. Europe Biosimilar Monoclonal Antibody Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Biosimilar Monoclonal Antibody Market Share by Country (2015-2020)
Table 41. China Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (US$ Million)
Table 42. China Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 43. China Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (US$ Million)
Table 44. China Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 45. China Biosimilar Monoclonal Antibody Market Size by Region (US$ Million) (2015-2020)
Table 46. China Biosimilar Monoclonal Antibody Market Share by Region (2015-2020)
Table 47. Japan Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 49. Japan Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 51. Japan Biosimilar Monoclonal Antibody Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Biosimilar Monoclonal Antibody Market Share by Country (2015-2020)
Table 53. Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Biosimilar Monoclonal Antibody Market Share by Type (2015-2020)
Table 55. Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Biosimilar Monoclonal Antibody Market Share by Application (2015-2020)
Table 57. Southeast Asia Biosimilar Monoclonal Antibody Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Biosimilar Monoclonal Antibody Market Share by Country (2015-2020)
Table 59. Biocon Company Details
Table 60. Biocon Business Overview
Table 61. Biocon Product
Table 62. Biocon Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 63. Biocon Recent Development
Table 64. Accord Healthcare Company Details
Table 65. Accord Healthcare Business Overview
Table 66. Accord Healthcare Product
Table 67. Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 68. Accord Healthcare Recent Development
Table 69. AET Biotech Company Details
Table 70. AET Biotech Business Overview
Table 71. AET Biotech Product
Table 72. AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 73. AET Biotech Recent Development
Table 74. Amgen Company Details
Table 75. Amgen Business Overview
Table 76. Amgen Product
Table 77. Amgen Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 78. Amgen Recent Development
Table 79. Celltrion Company Details
Table 80. Celltrion Business Overview
Table 81. Celltrion Product
Table 82. Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 83. Celltrion Recent Development
Table 84. Reddy's Laboratories Company Details
Table 85. Reddy's Laboratories Business Overview
Table 86. Reddy's Laboratories Product
Table 87. Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 88. Reddy's Laboratories Recent Development
Table 89. Hospira Company Details
Table 90. Hospira Business Overview
Table 91. Hospira Product
Table 92. Hospira Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 93. Hospira Recent Development
Table 94. 3SBio Business Overview
Table 95. 3SBio Product
Table 96. 3SBio Company Details
Table 97. 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 98. 3SBio Recent Development
Table 99. Allergan Company Details
Table 100. Allergan Business Overview
Table 101. Allergan Product
Table 102. Allergan Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 103. Allergan Recent Development
Table 104. Alvartis Company Details
Table 105. Alvartis Business Overview
Table 106. Alvartis Product
Table 107. Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2015-2020) (US$ Million)
Table 108. Alvartis Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilar Monoclonal Antibody Market Share by Type: 2020 VS 2026
Figure 2. Synthetic Chemicals Features
Figure 3. Biopharmaceuticals Features
Figure 4. Others Features
Figure 5. Global Biosimilar Monoclonal Antibody Market Share by Application: 2020 VS 2026
Figure 6. Chronic & Autoimmune Diseases Case Studies
Figure 7. Oncology Case Studies
Figure 8. Others Case Studies
Figure 9. Biosimilar Monoclonal Antibody Report Years Considered
Figure 10. Global Biosimilar Monoclonal Antibody Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Biosimilar Monoclonal Antibody Market Share by Regions: 2020 VS 2026
Figure 12. Global Biosimilar Monoclonal Antibody Market Share by Regions (2021-2026)
Figure 13. Global Biosimilar Monoclonal Antibody Market Share by Players in 2019
Figure 14. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibody as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2019
Figure 16. North America Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Biosimilar Monoclonal Antibody Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 44. Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 45. AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 46. Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 47. Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 48. Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 49. Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 50. 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 51. Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 52. Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs